Kalium LakesのEBITDA margin
Kalium LakesのEBITDA marginは何ですか。
Kalium Lakes LimitedのEBITDA marginは-412.10%です。
EBITDA marginの定義は何ですか。
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
ASXのセクタMaterialsにおけるEBITDA marginの企業と比べるKalium Lakes
Kalium Lakesは何をしますか。
Kalium Lakes Limited operates as an exploration and development company in Australia. It focuses on the development of 100% owned the Beyondie sulphate of potash project, which include 16 granted exploration licenses, two mining leases, and various miscellaneous licenses covering an area of approximately 1,800 square kilometers located in Western Australia. The company was founded in 2014 and is based in Balcatta, Australia.
Kalium Lakesと類似のebitda margin
- Vir Biotechnology IncのEBITDA marginは-415.62%です。
- OndasのEBITDA marginは-414.74%です。
- Axios Mobile AssetsのEBITDA marginは-414.57%です。
- NuhearaのEBITDA marginは-413.72%です。
- Alterity TherapeuticsのEBITDA marginは-412.91%です。
- Alterity TherapeuticsのEBITDA marginは-412.91%です。
- Kalium LakesのEBITDA marginは-412.10%です。
- Co-Diagnostics IncのEBITDA marginは-411.73%です。
- Atara BiotherapeuticsのEBITDA marginは-411.00%です。
- Opgen IncのEBITDA marginは-410.85%です。
- Titan MedicalのEBITDA marginは-408.50%です。
- Stroud ResourcesのEBITDA marginは-406.72%です。
- Last MileのEBITDA marginは-406.59%です。